platinum has been researched along with Cancer of Cervix in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (13.95) | 18.7374 |
| 1990's | 10 (23.26) | 18.2507 |
| 2000's | 3 (6.98) | 29.6817 |
| 2010's | 13 (30.23) | 24.3611 |
| 2020's | 11 (25.58) | 2.80 |
| Authors | Studies |
|---|---|
| Han, SB; He, Y; Liu, Y; Wu, YM; Zhang, JJ | 1 |
| Duenas-Gonzalez, A | 1 |
| He, ZY; Li, DC; Li, HY; Li, SJ; Liang, ZZ; Yan, J | 1 |
| Cao, Y; Chen, J; Hou, H; Li, C; Wang, J; You, J; Yuan, Z; Zhang, B; Zhu, L | 1 |
| Ma, L; Wang, R; Wu, Z; Xia, H; Xiao, Y | 1 |
| de Almeida, MS; de Andrade, DAP; de Melo, AC; Paulino, E | 1 |
| Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
| Hirata, T; Kawai, Y; Kishigami, Y; Kondo, E; Kotaka, S; Nagao, K; Okamoto, K; Suzuki, S; Yamawaki, T | 1 |
| Alma, MH; Altunoglu, YC; Atalar, MN; Aygun, A; Baloglu, MC; Gülbagca, F; Ozer, LY; Sen, F; Ustaoglu, B | 1 |
| Ishibashi, M; Nagai, T; Niikura, H; Sasaki, S; Shigeta, S; Shimada, M; Tokunaga, H; Toyoshima, M; Tsuji, K; Yaegashi, N | 1 |
| Adorni, M; Bazzurini, L; Buda, A; Grassi, T; Landoni, F; Lissoni, AA; Negri, S; Vecchione, F | 1 |
| Babu, S; Govind Babu, K; Jacob, L; Lakshmaiah, KC; Lokanatha, D; Lokesh, KN; Rajeev, LK; Rudresha, AH; Sridharmurthy, A; Thanky, AH | 1 |
| Ariyoshi, K; Kawano, H; Kitade, S; Kubo, Y; Kunitake, N; Minami, K; Nakamura, M; Okadome, M; Okushima, K; Saito, T; Shimamoto, K; Shimokawa, M | 1 |
| Fujimoto, E; Okame, S; Okazawa-Sakai, M; Shiroyama, Y; Takehara, K; Yokoyama, T | 1 |
| Alshatwi, AA; Athinarayanan, J; Vaiyapuri Subbarayan, P | 1 |
| Alshatwi, AA; Athinarayanan, J; Periasamy, VS | 1 |
| Du, B; Li, H; Ma, H; Wei, Q; Wu, D; Zhang, X; Zhang, Y | 1 |
| Hamasaki, T; Hashimoto, K; Isobe, A; Kawano, M; Kimura, T; Kozasa, K; Kuroda, H; Mabuchi, S; Matsumoto, Y; Morii, E; Sasano, T; Sawada, K; Takahashi, R | 1 |
| Brown, J; Burzawa, JK; Byers, LA; Coleman, RL; Frumovitz, M; Munsell, MF; Ramalingam, P | 1 |
| Cohen, C; Hanley, KZ; Horowitz, IR; Khanna, N; Rubinsak, LA | 1 |
| Chen, G; Chen, Y; Cheng, X; Gao, Q; Hu, J; Hu, T; Huang, K; Jia, Y; Li, S; Li, X; Lv, W; Ma, D; Shen, J; Sun, H; Suolang, Q; Tang, F; Wang, H; Wang, L; Wang, S; Wang, X; Wu, L; Xi, L; Xie, X; Xing, H; Yang, R; Yao, Y; Zhang, Q; Zhou, H; Zhou, J; Zhou, S | 1 |
| Ito, K; Kaneyasu, Y; Komatsu, M; Nagai, N; Oshita, T; Shiroyama, Y; Watasaki, S | 1 |
| Chun, KC; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH | 1 |
| Hamada, Y; Hayakawa, K; Kotani, A; Kusu, F; Naitoh, H; Niibe, Y; Takayanagi, R; Tsunoda, S; Unno, N; Yago, K; Yamada, Y | 1 |
| Aguilera, RJ; Contel, M; González-Pantoja, JF; Jarzecki, AA; Robles-Escajeda, E; Royo, E; Stern, M; Varela-Ramírez, A | 1 |
| Ito, K; Nagase, S; Nemoto, K; Niikura, H; Ogawa, Y; Takano, T; Yaegashi, N; Yoshinaga, K | 1 |
| Crisp, WE; Marin, AC | 1 |
| Hayase, R; Kodama, J; Kudoh, T; Tamada, T; Yamamoto, J; Yamamoto, M | 1 |
| Murakami, T; Nagai, N; Ohama, K | 1 |
| Hamada, M; Kohso, T; Shimamoto, T; Tateyama, H | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Bondiau, PY; Chauvel, P; Etienne, MC; Lagrange, JL; Milano, G; Renée, N; Tessier, E | 1 |
| Cheng, X; Irie, T; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Okada, M; Terakawa, N | 1 |
| Hattori, S; Inoue, T; Ishikawa, H; Kikkawa, F; Matsuzawa, K; Suganuma, N; Tamakoshi, K; Tokuhashi, Y; Tomoda, Y | 1 |
| Areberg, J; Johnsson, A; Wennerberg, J | 1 |
| Barter, JF; Hatch, KD; Orr, JW; Shingleton, HM; Soong, SJ | 1 |
| Hirabayashi, K; Oguma, T; Okada, E; Shimamura, K | 1 |
| Chauvel, P; Courdi, A; Fontana, X; Lagrange, JL; Milano, G; Troger, V | 1 |
| Ebihara, T; Fukushima, M; Kawakami, S; Maruyama, K; Sawada, T; Tateyama, Y; Yoshimura, Y | 1 |
| Delobelle, A; Demaille, MC; Fournier, C; Hecquet, B; Lequint, A; Poissonnier, B; Vennin, P | 1 |
| Adenis, L; Bonneterre, J; Caty, A; Demaille, A; Fournier, C; Hecquet, B; Lefebvre, JL; Vennin, P | 1 |
| Creasey, WA; DeConti, RC; Lange, RC; Toftness, BR | 1 |
| Harder, HC; Lange, RC; Spencer, RP | 1 |
3 review(s) available for platinum and Cancer of Cervix
| Article | Year |
|---|---|
Combinational therapies for the treatment of advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Combined Modality Therapy; Female; Humans; Paclitaxel; Platinum; Uterine Cervical Neoplasms | 2023 |
Systemic therapy for advanced cervical cancer: Leveraging the historical threshold of overall survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Immunotherapy; Platinum; Platinum Compounds; Uterine Cervical Neoplasms | 2023 |
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
7 trial(s) available for platinum and Cancer of Cervix
| Article | Year |
|---|---|
A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Cervical Neoplasms | 2022 |
Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Humans; Immune Checkpoint Inhibitors; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Uterine Cervical Neoplasms; Young Adult | 2022 |
Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Combined Modality Therapy; Female; Genitalia, Female; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Neoplasm Staging; Platinum; Radiotherapy; Uterine Cervical Neoplasms | 2009 |
Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Organoplatinum Compounds; Platinum; Radioisotope Teletherapy; Uterine Cervical Neoplasms | 2007 |
Neoadjuvant chemotherapy using a platinum, vincristine and peplomycin (CVP) combination in patients with carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Peplomycin; Platinum; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 1993 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Comparative study of intravenous and intraarterial cis-platinum on intratumoral platinum concentration in carcinoma of the cervix.
Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Middle Aged; Platinum; Uterine Cervical Neoplasms | 1989 |
33 other study(ies) available for platinum and Cancer of Cervix
| Article | Year |
|---|---|
Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
Topics: Apolipoprotein A-I; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Phosphatidylinositol 3-Kinases; Platinum; Uterine Cervical Neoplasms | 2022 |
Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Cervix Uteri; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Platinum; Pregnancy; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2022 |
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Humans; Paclitaxel; Pilot Projects; Platinum; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
Biogenic platinum nanoparticles using black cumin seed and their potential usage as antimicrobial and anticancer agent.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Inhibitory Concentration 50; Metal Nanoparticles; Nigella sativa; Plant Extracts; Platinum; Seeds; Uterine Cervical Neoplasms | 2020 |
A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Platinum; Prospective Studies; Uterine Cervical Neoplasms | 2021 |
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2022 |
Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern India.
Topics: Developing Countries; Female; Humans; India; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Tertiary Care Centers; Uterine Cervical Neoplasms | 2017 |
Renal function and urological complications after radical hysterectomy with postoperative radiotherapy and platinum-based chemotherapy for cervical cancer.
Topics: Adult; Aged; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hysterectomy; Intraoperative Care; Kidney; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pelvis; Platinum; Postoperative Complications; Prognosis; Propensity Score; Time Factors; Uterine Cervical Neoplasms | 2018 |
Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Platinum; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Uterine Cervical Neoplasms; Young Adult | 2018 |
Green synthesis of platinum nanoparticles that induce cell death and G2/M-phase cell cycle arrest in human cervical cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Division; Cell Line, Tumor; Female; G2 Phase; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Platinum; Uterine Cervical Neoplasms; X-Ray Diffraction | 2015 |
Green synthesis of bimetallic Au@Pt nanostructures and their application for proliferation inhibition and apoptosis induction in human cervical cancer cell.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Platinum; Uterine Cervical Neoplasms | 2015 |
Signal Amplification Strategy of Triple-Layered Core-Shell Au@Pd@Pt Nanoparticles for Ultrasensitive Immunoassay Detection of Squamous Cell Carcinoma Antigen.
Topics: Antigens, Neoplasm; Biosensing Techniques; Early Detection of Cancer; Enzyme-Linked Immunosorbent Assay; Female; Gold; Humans; Immunoassay; Limit of Detection; Nanoshells; Palladium; Platinum; Sensitivity and Specificity; Serpins; Signal Processing, Computer-Assisted; Uterine Cervical Neoplasms | 2015 |
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Granulocyte Colony-Stimulating Factor; Mice; Myeloid Cells; Platinum; Prognosis; Uterine Cervical Neoplasms | 2015 |
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carcinoma, Neuroendocrine; Disease Progression; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Paclitaxel; Platinum; Retrospective Studies; Survival Rate; Topotecan; Uterine Cervical Neoplasms; Young Adult | 2017 |
Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Female; Folate Receptor 1; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Ovarian Neoplasms; Platinum; Uterine Cervical Neoplasms | 2018 |
Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Asian People; Drug Therapy; Female; Genome-Wide Association Study; Humans; Middle Aged; Platinum; Polymorphism, Single Nucleotide; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2017 |
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoadjuvant Therapy; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms | 2010 |
Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Pilot Projects; Platinum; Thrombocytopenia; Uterine Cervical Neoplasms | 2010 |
Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Circular Dichroism; DNA; Female; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Nucleic Acid Conformation; Organometallic Compounds; Palladium; Phosphines; Platinum; Prostatic Neoplasms; Spectrophotometry, Infrared; Structure-Activity Relationship; Titanium; Uterine Cervical Neoplasms | 2011 |
A new indication for colposcopy: predicting tumor response to chemotherapy.
Topics: Colposcopy; Female; Humans; Platinum; Uterine Cervical Neoplasms | 1980 |
[Pt levels following the infusion of daily low-dose cisplatin].
Topics: Cisplatin; Female; Humans; Infusions, Intravenous; Ovarian Neoplasms; Platinum; Uterine Cervical Neoplasms | 1995 |
[Distribution of platinum in the female genital tract after intraarterial carboplatin infusion during the operation of uterine cervical cancer].
Topics: Adenocarcinoma; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Genitalia, Female; Humans; Infusions, Intra-Arterial; Intraoperative Care; Lymph Nodes; Platinum; Uterine Cervical Neoplasms | 1994 |
Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer.
Topics: Aged; Antineoplastic Agents; Cisplatin; Female; Humans; Middle Aged; Platinum; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 1996 |
Clinical responses and platinum concentrations in tumors after intra-arterial and intravenous administration of cisplatin in the same patients with cervical cancer.
Topics: Adult; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Platinum; Treatment Outcome; Uterine Cervical Neoplasms | 1997 |
Distribution of platinum in human gynecologic tissues and pelvic lymph nodes after administration of cisplatin.
Topics: Adult; Aged; Antineoplastic Agents; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Hysterectomy; Infusions, Intravenous; Lymph Node Excision; Lymph Nodes; Middle Aged; Myometrium; Ovary; Platinum; Spectrophotometry, Atomic; Treatment Outcome; Uterine Cervical Neoplasms | 1997 |
In vitro toxicity of (191)Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180).
Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Combined Modality Therapy; DNA, Neoplasm; Drug Synergism; Female; Humans; Platinum; Radioisotopes; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2000 |
Diagnosis and treatment of pulmonary metastases from cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Lung Neoplasms; Middle Aged; Platinum; Retrospective Studies; Risk Factors; Survival Analysis; Uterine Cervical Neoplasms | 1990 |
[Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
Topics: Aged; Antineoplastic Agents; Biological Assay; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Organoplatinum Compounds; Peritonitis; Platinum; Stomach Neoplasms; Uterine Cervical Neoplasms | 1990 |
Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser.
Topics: Adult; Aged; Cisplatin; Drug Evaluation; Female; Half-Life; Humans; Longitudinal Studies; Middle Aged; Platinum; Radiation-Sensitizing Agents; Spectrophotometry, Atomic; Uterine Cervical Neoplasms | 1990 |
[Balloon occluded arterial infusion (BOAI) therapy in patients with progressive cervical carcinoma].
Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Catheterization; Cisplatin; Embolization, Therapeutic; Evaluation Studies as Topic; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Platinum; Remission Induction; Tissue Distribution; Uterine Cervical Neoplasms | 1989 |
Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.
Topics: Breast Neoplasms; Cisplatin; Female; Head and Neck Neoplasms; Humans; Kinetics; Platinum; Uterine Cervical Neoplasms | 1985 |
Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).
Topics: Adult; Aged; Amines; Antineoplastic Agents; Chlorides; DNA, Neoplasm; Female; Gastrointestinal Neoplasms; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Platinum; Thymidine; Uterine Cervical Neoplasms | 1973 |
The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Brain; Female; Humans; Intestine, Small; Kidney; Liver; Lung; Lymphoma; Male; Myocardium; Neoplasm Transplantation; Platinum; Radioisotopes; Sarcoma 180; Skull; Spleen; Uterine Cervical Neoplasms | 1973 |